Education & Outreach

Research Link

Research Link

Study Participation Link

Study Participation Link

Nicotine Information Link

Nicotine Information Link

Studies

Quit Smoking Studies

Research Studies

Listed by Contributor

Loading...
Expand All | Collapse All

Dr. Jed Rose

1990-1995

[] []35 Development of a citric acid aerosol as a smoking cessation aid, 1990.pdf
[] []36 Transdermal nicotine facilitates smoking cessation, 1990.pdf
[] []37 Characterization of the cognitive effects of combined muscarinic and nicotinic blockade, 1990.pdf
[] []38 Chronic nicotine and withdrawal effects on radial-arm maze performance, 1990.pdf
[] []39 The use of flavor in cigarette substitutes, 1990.pdf
[] []40 Cholinergic-dopaminergic interactions in cognitive performance, 1990.pdf
[] []41 Effects of controlled nicotine doses upon punished and non-punished responding in humans, 1990.pdf
[] []44 Psychophysiological interactions between caffeine and nicotine, 1991.pdf
[] []45 Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking, 1991.pdf
[] []47 Interactive effects of D1 and D2 agonists with scopolamine and radial-arm maze performance, 1991.pdf
[] []48 Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze, 1991.pdf
[] []49 The effects of smoking-related sensory cues on psychological stress, 1991.pdf
[] []50 Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC, 1991.pdf
[] []51 Tar, CO and Delta-9-THC delivery from the 1st and 2nd halves of a marijuana cigarette, 1991.pdf
[] []52 Concurrent agonist-antagonist administration for the analysis and treatment of druge dependence, 1992.pdf
[] []54 Persistence of chronic nicotine-induced cognitive facilitation, 1992.pdf
[] []55 Clinical evaluation of a citric acid inhaler for smoking cessation, 1993.pdf
[] []56 Sertraline attenuates hyperphagia in rats following nicotine withdrawal, 1993.pdf
[] []57 Role of nicotine dose and sensory cues in the regulation of smoke intake, 1993.pdf
[] []59 Effectiveness of the nicotine patch in smoking cessation; A randomized controlled trial with telephone counseling, 1993.pdf
[] []60 Clinical trials using ascorbic acid aerosol to aid smoking cessation, 1993.pdf
[] []62 Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or the medial basalocortical projection, 1993.pdf
[] []63 Prenatal nicotine exposure and cognitive performance in rats, 1993.pdf
[] []65 Intracerebroventricular nicotine and mecamylamine alter radial-arm maze performance in rats, 1994.pdf
[] []67 Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms, 1994.pdf
[] []68 Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low-tar cigarettes, 1994.pdf
[] []69 Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone, 1994.pdf
[] []70 Combined effects of nicotine and mecamylamine in attenuating smoking reward, 1994.pdf
[] []72 Smoking in Vietnam combat veterans with posttraumatic stress disorder, 1995.pdf
[] []75 Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze, 1995.pdf
[] []76 Airway sensory replacement combined with nicotine replacement for smoking cessation; A randomized, placebo controlled trial using a citric acid inhaler, 1995.pdf
[] []77 Effects of cigarette smoking on perception of thermal pain, 1995.pdf
[] []78 Effects of caffeine intake on smoking behavior in the natural environment, 1995.pdf
[] []81 Clozapine decreases smoking in patients with chronic schizophrenia, 1995.pdf
[] []82 Haloperidol increases smoking in patients with schizophrenia, 1995.pdf

1996-2000

[] []83 Nicotine addiction and treatment, 1996.pdf
[] []84 Airway sensory replacement as a treatment for smoking cessation, 1996.pdf
[] []85 Dissociating the nicotine and airway sensory effects of smoking, 1996.pdf
[] []86 Nicotine-haloperidol interactions and cognitive performance in schizophrenics, 1996.pdf
[] []87 Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD), 1996.pdf
[] []88 Nicotine effects on adults with attention deficit-hyperactivity disorder, 1996.pdf
[] []89 Do heavy smokers need a higher replacement dose of nicotine to quit, 1996.pdf
[] []91 Combination nicotine-mecamylamine treatment for smoking cessation, 1996.pdf
[] []92 Quitting smoking raises whole blood glutathione, 1996.pdf
[] []94 Smoking behavior on the first day of a quit attempt predicts long-term abstinence, 1997.pdf
[] []95 Nicotine self-administration in animals and humans; Similarities and differences, 1997.pdf
[] []96 Nicotine-mecamylamine treatment for smoking cessation; the role of pre-cessation therapy, 1998.pdf
[] []97 Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan, 1999.pdf
[] []98 Naltrexone blockade of nicotine effects in cigarette smokers, 1999.pdf
[] []99 Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration; implications for addiction, 1999.pdf
[] []100 Dissociating nicotine and nonnicotine components of cigarette smoking, 2000.pdf
[] []101 Nicotine delivery systems for smoking cessation, 2000.pdf
[] []102 Combining the nicotine inhaler and nicotine patch for smoking cessation, 2000.pdf
[] []103 The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats, 2000.pdf

2001-2005

[] []104 Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking, 2001.pdf
[] []105 Individual differences in smoking reward from denicotinized cigarettes, 2001.pdf
[] []107 Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms, 2001.pdf
[] []108 Oral nicotine solution for smoking cessation; A pilot tolerability study, 2001.pdf
[] []109 Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes, 2001.pdf
[] []110 Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol, 2002.pdf
[] []111 PET Studies of the influences of nicotine on neural systems in cigarette smokers, 2003.pdf
[] []112 Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia, 2003.pdf
[] []113 Adolescent-onset nicotine self-administration modeled in female rats, 2003.pdf
[] []114 Mecamylamine acutely increases human intravenous nicotine self-administration, 2003.pdf
[] []115 Pharmacologic and sensorimotor components of satiation in cigarette smoking, 2003.pdf
[] []116 Psychopharmacologic interactions between nicotine and ethanol, 2004.pdf
[] []117 Effects of low nicotine content cigarettes on smoke intake, 2004.pdf
[] []118 Extinguishing the rewarding value of smoke cues; Pharmacological and behavioral treatments, 2004.pdf
[] []119 Mecamylamine moderates cue-induced emotional responses in smokers, 2005.pdf
[] []120 Ethics of tobacco company funding, 2005.pdf
[] []121 Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder, 2005.pdf
[] []122 Abstinence-induced changes in self-report craving correlate with event-related fMRI responses to smoking cues, 2005.pdf

2006-2010

[] []123 Pre-cessation treatment with nicotine skin patch facilitates smoking cessation, 2006.pdf
[] []124 Nicotine and nonnicotine factors in cigarette addiction, 2006.pdf
[] []125 Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers, 2006.pdf
[] []126 Guidelines for nicotine dose selection for in vivo research, 2007.pdf
[] []128 Transdermal nicotine attenuates depression symptoms in nonsmokers; a double-blind, placeboâ��controlled study, 2006.pdf
[] []129 Regional brain activity correlates of nicotine dependence, 2007.pdf
[] []130 Molecular genetics of nicotine dependence and abstinence; whole genome association using 520,000 SNPs, 2007.pdf
[] []131 The effects of foods, beverages and other factors on cigarette palatability, 2007.pdf
[] []132 Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation; Results of a preliminary fMRI study, 2007.pdf
[] []133 Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility, 2007.pdf
[] []134 DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues, 2007.pdf
[] []135 Multiple brain pathways and receptors underlying tobacco addiction, 2007.pdf
[] []136 Denicotinized cigarettes; a new tool to combat cigarette addiction, 2007.pdf
[] []137 Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder; results of a preliminary study, 2008.pdf
[] []138 Molecular genetics of successful smoking cessation; Convergent genome-wide association study results, 2008.pdf
[] []139 Pre-cessation varenicline treatment vs. post-cessation NRT; An uneven playing field, 2008.pdf
[] []140 Disrupting nicotine reinforcement; From cigarette to brain, 2008.pdf
[] []141 Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues, 2008.pdf
[] []142 A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation, 2008.pdf
[] []143 Nicotine abstinence genotyping; assessing the impact on smoking cessation clinical trials, 2009.pdf
[] []144 Brain nicotinic acetylcholine receptor occupancy; effect of smoking a denicotinized cigarette, 2009.pdf
[] []145 Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats, 2008.pdf
[] []146 Neuroanatomical relationships of substance P immunoreactive intrapulmonary C-Fibers and nicotinic cholinergic receptors, 2009.pdf
[] []147 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum, 2009.pdf
[] []148 Nicotinic alpha-7 or beta-2 containing receptor knockout; Effects on radial-arm maze learning and long-term nicotine consumption in mice, 2009.pdf
[] []149 New findings in nicotine addiction and treatment, 2009.pdf
[] []150 Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment, 2009.pdf
[] []151 Genome wide association for smoking cessation success; participants in a trial with adjunctive denicotinized cigarettes, 2009.pdf
[] []152 Sazetidine-A, a selective alpha-4 beta-2 nicotinic receptor desensitizing agent and partial agonist reduces nicotine self-administration in rats, 2010.pdf
[] []153 Nicotinic receptors in the habenula; importance for memory, 2010.pdf
[] []154 Kinetics of brain nicotine accumulation in dependent and non-dependent smokers assessed with PET and cigarettes containing 11C-nicotine, 2010.pdf
[] []156 Genome-wide meta-analyses identify multiple loci associated with smoking behavior, 2010.pdf
[] []157 Effects of sazetidine-A ... on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats, 2010.pdf
[] []158 Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition, 2010.pdf
[] []159 Hippocampal and striatal grey matter volume are associated with a smoking cessation treatment outcome; Results of an exploratory voxel-based morphometric analysis, 2010.pdf
[] []160 Reinforcing effects of nicotine and non-nicotine components of cigarette smoke, 2010.pdf
[] []161 Stress alleviation and reward enhancement; Two promising targets for relapse prevention, 2010.pdf
[] []162 Pulmonary delivery of nicotine pyruvate; sensory and pharmacokinetic characteristics, 2010.pdf
[] []163 Silver acetate interactions with nicotine and non-nicotine smoke components, 2010.pdf
[] []166 IV nicotine self-administration in rats using the consummatory operant licking response, 2010.pdf

2011

[] []164 Individualized smoking cessation treatment; roles for sets of genomic markers, 2011.pdf
[] []165 D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response, 2011.pdf
[] []167 Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats, 2011.pdf
[] []168 Nicotine preloading; the importance of a pre-cessation reduction in smoking behavior, 2011.pdf
[] []169 Menthol preference among smokers; association With TRPA1 variants, 2011.pdf
[] []169 menthol preference among smokers association with trpa1 variants 2011.pdf
[] []170 rTMS Superior frontal gyrus modulates craving for cig., 2011.pdf
[] []170 rtms superior frontal gyrus modulates craving for cig. 2011.pdf

Presentations

[] []index.html

[] []index.html

©2012 Duke Center for Smoking Cessation. All Rights Reserved.

Education & Outreach